Fresno Heart Hospital posted Antinuclear antibodies affect outcomes in NSCLC patients treated with PD-1 inhibitors Fresno Heart Hospital Woodward Park - Fresno:

Antinuclear antibodies affect outcomes in NSCLC patients treated with PD-1 inhibitors

Researchers undertook this retrospective study in patients with advanced (stage III or IV) or recurrent NSCLC to determine whether the presence of ANAs had any effect on the safety and efficacy of PD-1 inhibitors.

Antinuclear antibodies affect outcomes in NSCLC patients treated with PD-1 inhibitors
QR Code
Embed the QR code on your website:
Download
Copy